The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict WellPoint's revenues will increase 17.6% and EPS will increase 3.4%.
The average estimate for revenue is $17.84 billion. On the bottom line, the average EPS estimate is $2.11.
Last quarter, WellPoint tallied revenue of $17.55 billion. GAAP reported sales were 15% higher than the prior-year quarter's $15.42 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $2.94. GAAP EPS of $2.89 for Q1 were 14% higher than the prior-year quarter's $2.53 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 22.3%, 130 basis points worse than the prior-year quarter. Operating margin was 8.1%, 110 basis points worse than the prior-year quarter. Net margin was 5.0%, 60 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $71.22 billion. The average EPS estimate is $8.07.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 937 members out of 996 rating the stock outperform, and 59 members rating it underperform. Among 320 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 313 give WellPoint a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WellPoint is outperform, with an average price target of $71.69.
Is WellPoint the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add WellPoint to My Watchlist.